Company Intelligence
Beacon Biosignals
Beacon Biosignals provides enterprise-grade artificial intelligence solutions, delivering specialized Beacon Biosignals Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Boston, United States
- Website
- beacon.bio
- Founded
- 2019
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Beacon Biosignals is a Healthcare AI company based in Boston, United States, founded in 2019.
Boston AI-driven sleep EEG and wearable neurotechnology platform for clinical trials and brain-health analytics.
Verified founder profiles on Brel: Jacob Donoghue MD, Jacob Donoghue.
What it builds
Beacon Biosignals Platform
Why It Matters
Beacon Biosignals provides enterprise-grade artificial intelligence solutions, delivering specialized Beacon Biosignals Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Funding
Verified funding disclosures on file for this company.
- April 6, 2026: Beacon announced Series B extension bringing round total to $97 million and cumulative funding to over $132 million.
Products
Products and platforms connected to this company.
-
Beacon Platform
Explore Beacon Platform by Beacon Biosignals. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Beacon Biosignals
Industry
Industries served
- Biotechnology
Products
Capabilities
Beacon applies deep learning to sleep EEG signals captured by wearable headbands, producing biomarkers pharma teams embed as exploratory or secondary endpoints…
Features
- Beacon Platform combining FDA-cleared wearable EEG (Waveband, formerly Dreem 3S) with AI analytics for sleep, neurology
- FDA-cleared wearable EEG (Waveband
- formerly Dreem 3S) with AI analytics for sleep
- neurology
- psychiatry — serving biopharma clinical trials
- diagnostics
- at-home brain monitoring programs
Country
Use cases
Related companies
Official Resources
Official and developer links on file for this company.
Latest Developments
Verified developments and timeline notes on file.
Frequently Asked Questions
What does Beacon Biosignals do?
Beacon Biosignals specializes in artificial intelligence, developing Beacon Biosignals Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Beacon Biosignals based and when was it founded?
Beacon Biosignals is based in United States and was founded in 2019.
What are the main products offered by Beacon Biosignals?
The flagship platform from Beacon Biosignals is Beacon Biosignals Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Beacon Biosignals?
Beacon Biosignals primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.